Safety Signals of CRS and ICANS With Tarlatamab in Relapsed Small Cell Lung Cancer: Insights From a Small Case Study.

Saved in:
Bibliographic Details
Title: Safety Signals of CRS and ICANS With Tarlatamab in Relapsed Small Cell Lung Cancer: Insights From a Small Case Study.
Authors: Choi J; Division of Pulmonary, Allergy, and Critical Care Medicine Department of Internal Medicine Korea, University Guro Hospital Korea University College of Medicine, Seoul, Republic of Korea., Lee S; Division of Pulmonary, Allergy, and Critical Care Medicine Department of Internal Medicine Korea, University Guro Hospital Korea University College of Medicine, Seoul, Republic of Korea., Lee SY; Division of Pulmonary, Allergy, and Critical Care Medicine Department of Internal Medicine Korea, University Guro Hospital Korea University College of Medicine, Seoul, Republic of Korea.
Source: Thoracic cancer [Thorac Cancer] 2026 Sep; Vol. 17 (18), pp. e70389.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print Cited Medium: Internet ISSN: 1759-7714 (Electronic) Linking ISSN: 17597706 NLM ISO Abbreviation: Thorac Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-7714
DOI:10.1111/1759-7714.70389